Pulse Biosciences, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 10.14 million compared to USD 9.8 million a year ago. Basic loss per share from continuing operations was USD 0.18 compared to USD 0.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.37 USD | -4.85% | +45.58% | -7.11% |
May. 20 | Pulse Biosciences Moves New Record Date for Rights Offering | MT |
May. 14 | Pulse Biosciences Appoints Burke Barrett as President, CEO | MT |
1st Jan change | Capi. | |
---|---|---|
-7.11% | 628M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024